Fund Purchaser Qualified Partners Venture Skyline IV Acelrx Pharmaceuticals Inc

As of March 11, 2014


What is Fund Purchaser Qualified Partners Venture Skyline IV's Net Worth?

The current estimated net worth of Acelrx Pharmaceuticals Inc's Fund Purchaser Qualified Partners Venture Skyline IV is estimated to be about $21.63M . Fund Purchaser Qualified Partners Venture Skyline IV owns about 4,161,933 units of Acelrx Pharmaceuticals Inc common stock. In the last 3 years at Acelrx Pharmaceuticals Inc, Fund Purchaser Qualified Partners Venture Skyline IV has sold an estimated value of $0 worth.

What is Fund Purchaser Qualified Partners Venture Skyline IV's Past Insider Trading?

Fund Purchaser Qualified Partners Venture Skyline IV's largest purchase order was 3,887,235 units , worth over $6.18M on February 18, 2011. In total, Fund Purchaser Qualified Partners Venture Skyline IV has made about 3 transactions over 3 years of their time at Acelrx Pharmaceuticals Inc. Fund Purchaser Qualified Partners Venture Skyline IV usually trades in March, February and May, with the busiest year in 2011, 2014 and 2012. The most recent transaction was a purchase order of 284,698 units , worth over $967.97K on May 31, 2012.

Fund Purchaser Qualified Partners Venture Skyline IV, Skyline Venture Management IV LLC, Gordon John Freund, YASUNORI KANEKO

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Fund Purchaser Qualified Partners Venture Skyline IV's' Mailing Address?

  • Mailing address is 125 University Ave Palo Alto CA 94301 CA

What are Acelrx Pharmaceuticals Inc's Past Insider Trades?

Acelrx Pharmaceuticals Inc's most recent insider trade came on June 8, 2022 by Vincent Angotti who bought 46,400 units worth $10.33K . In the last 11 years, insiders at Acelrx Pharmaceuticals Inc have sold an estimated value of $23.82M and bought an estimated value of $52.86M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Lawrence Hamel, Chief Development Officer,  Badri Dasu, Chief Engineering Officer,  and Pamela Palmer, Chief Medical Officer .

ACELRX PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1